O'Shaughnessy Asset Management’s Royalty Pharma RPRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	23,810 -3,630	-13%	-$189K	0.01%	1106
2026 Q1	$1.32M	Buy	27,440 +4,872	+22%	+$213K	0.01%	1061
2025 Q4	$872K	Buy	22,568 +43	+0.2%	+$1.64K	﹤0.01%	1213
2025 Q3	$795K	Buy	22,525 +2,399	+12%	+$86.8K	﹤0.01%	1228
2025 Q2	$725K	Buy	20,126 +2,141	+12%	+$70.9K	﹤0.01%	1193
2025 Q1	$560K	Buy	+17,985	New	+$570K	﹤0.01%	1261
2024 Q4	–	Sell	-10,898	Closed	-$304K	–	2280
2024 Q3	$304K	Buy	+10,898	New	+$302K	﹤0.01%	1483

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Shaughnessy Asset Management's RPRX Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Royalty Pharma (RPRX) stake by 13% in Q2 2026, selling an estimated $189K and leaving 23,810 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #1106.

O'Shaughnessy Asset Management first reported a position in RPRX in Q3 2024 and has held it in 7 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

O'Shaughnessy Asset Management held 23,810 shares of Royalty Pharma worth $1.34M as of Q2 2026.
O'Shaughnessy Asset Management sold 3,630 Royalty Pharma shares in Q2 2026, an estimated $189K.
Royalty Pharma made up 0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1106 holding.
O'Shaughnessy Asset Management first reported a position in Royalty Pharma in Q3 2024 and has held it in 7 quarters since.
647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.